As a control for infection, mice lacking the ability to respond to IL-17 (Act1–/–, housed in SPF conditions) were confirmed to be susceptible to OPC, at levels somewhat higher than GF- or Abx-treated mice (~104 CFU/g). This evidence concerns the gene TRAF3IP2 and infection.